Literature DB >> 26137101

Eukaryotic translation initiation factor 3, subunit C is overexpressed and promotes cell proliferation in human glioma U-87 MG cells.

Jinmin Hao1, Chaohui Liang1, Baohua Jiao1.   

Abstract

Disrupted protein translation is prevalent in tumours. Eukaryotic translation initiation factors (eIFs) were found to play an important role in various tumours. However, the involvement of eIFs in glioma remains to be elucidated. The present study explored the expression and the role of eIF 3, subunit C (eIF3c) in human glioma. The expression of eIF3c in glioma tissues was evaluated by immunohistochemistry. The impact of eIF3c inhibition on U-87 MG was explored in vitro and in vivo by lentivirus-mediated siRNA targeting eIF3c. The results revealed that overexpression of eIF3c was present in glioma tissues. Knockdown of eIF3c significantly impaired cell proliferation and colony formation, further induced cell cycle arrest and apoptosis in the U-87 MG cell line. Furthermore, tumoursphere formation in the U-87 MG glioma xenograft model was blocked by eIF3c knockdown. The involvement of eIF3c in the tumorigenesis of glioma was confirmed, suggesting eIF3c may be a promising therapy target in human glioma.

Entities:  

Keywords:  apoptosis; cell proliferation; eukaryotic translation initiation factor 3; glioma; protein translation; subunit 3

Year:  2015        PMID: 26137101      PMCID: PMC4473432          DOI: 10.3892/ol.2015.3078

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  28 in total

Review 1.  [Clinical trial updates for malignant brain tumors].

Authors:  Toshihiko Wakabayashi
Journal:  Rinsho Shinkeigaku       Date:  2011-11

Review 2.  Translational control in cellular and developmental processes.

Authors:  Jian Kong; Paul Lasko
Journal:  Nat Rev Genet       Date:  2012-06       Impact factor: 53.242

3.  mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events.

Authors:  Marina K Holz; Bryan A Ballif; Steven P Gygi; John Blenis
Journal:  Cell       Date:  2005-11-18       Impact factor: 41.582

4.  eIF3c: a potential therapeutic target for cancer.

Authors:  Rafi Emmanuel; Shiri Weinstein; Dalit Landesman-Milo; Dan Peer
Journal:  Cancer Lett       Date:  2013-04-25       Impact factor: 8.679

5.  Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States.

Authors:  Stuart A Grossman; Xiaobu Ye; Steven Piantadosi; Serena Desideri; Louis B Nabors; Myrna Rosenfeld; Joy Fisher
Journal:  Clin Cancer Res       Date:  2010-04-06       Impact factor: 12.531

6.  Knockdown of eukaryotic translation initiation factors 3B (EIF3B) inhibits proliferation and promotes apoptosis in glioblastoma cells.

Authors:  Hong Liang; Xuehua Ding; Chun Zhou; Yihua Zhang; Minhui Xu; Chengqu Zhang; Lunshan Xu
Journal:  Neurol Sci       Date:  2012-01-11       Impact factor: 3.307

7.  Cancer stem cells in solid tumors: is 'evading apoptosis' a hallmark of cancer?

Authors:  Heiko Enderling; Philip Hahnfeldt
Journal:  Prog Biophys Mol Biol       Date:  2011-04-05       Impact factor: 3.667

Review 8.  Epidemiology of brain tumors.

Authors:  Hiroko Ohgaki
Journal:  Methods Mol Biol       Date:  2009

9.  Dissecting eIF4E action in tumorigenesis.

Authors:  Hans-Guido Wendel; Ricardo L A Silva; Abba Malina; John R Mills; Hong Zhu; Takeshi Ueda; Rie Watanabe-Fukunaga; Rikiro Fukunaga; Julie Teruya-Feldstein; Jerry Pelletier; Scott W Lowe
Journal:  Genes Dev       Date:  2007-11-30       Impact factor: 11.361

10.  iASPP is over-expressed in human non-small cell lung cancer and regulates the proliferation of lung cancer cells through a p53 associated pathway.

Authors:  Jinfeng Chen; Fei Xie; Lijian Zhang; Wen G Jiang
Journal:  BMC Cancer       Date:  2010-12-30       Impact factor: 4.430

View more
  9 in total

Review 1.  Translation initiation factors and their relevance in cancer.

Authors:  Columba de la Parra; Beth A Walters; Phillip Geter; Robert J Schneider
Journal:  Curr Opin Genet Dev       Date:  2017-11-16       Impact factor: 5.578

2.  EIF3C-enhanced exosome secretion promotes angiogenesis and tumorigenesis of human hepatocellular carcinoma.

Authors:  Hsin-Yi Lee; Chi-Kuan Chen; Chun-Ming Ho; Szu-Shuo Lee; Chieh-Yu Chang; Kuan-Ju Chen; Yuh-Shan Jou
Journal:  Oncotarget       Date:  2018-01-11

3.  Knockdown of EIF3C promotes human U-2OS cells apoptosis through increased CASP3/7 and Chk1/2 by upregulating SAPK/JNK.

Authors:  Weilu Gao; Yong Hu; Zhengqin Zhang; Gongwen Du; Li Yin; Zongsheng Yin
Journal:  Onco Targets Ther       Date:  2019-02-14       Impact factor: 4.147

4.  Eukaryotic initiation factor 3, subunit C silencing inhibits cell proliferation and promotes apoptosis in human ovarian cancer cells.

Authors:  Fang Wen; Zhang-Ying Wu; Lei Nie; Qi-Zhu Zhang; Yuan-Kun Qin; Zun-Lun Zhou; Jin-Jian Wu; Xing Zhao; Jun Tan; Darrell Sawmiller; Dan Zi
Journal:  Biosci Rep       Date:  2019-08-05       Impact factor: 3.840

5.  Translational Regulation by hnRNP H/F Is Essential for the Proliferation and Survival of Glioblastoma.

Authors:  Morgane Le Bras; Noah Gorelick; Sylvain Pautet; Betty Tyler; Stéphane Manenti; Nicolas Skuli; Stefania Millevoi; Anne Cammas
Journal:  Cancers (Basel)       Date:  2022-03-02       Impact factor: 6.639

Review 6.  The immune landscape of hepatocellular carcinoma-where we are?

Authors:  Maciej Gryziak; Krzysztof Wozniak; Leszek Kraj; Letycja Rog; Rafal Stec
Journal:  Oncol Lett       Date:  2022-09-27       Impact factor: 3.111

7.  Decreasing Eukaryotic Initiation Factor 3C (EIF3C) Suppresses Proliferation and Stimulates Apoptosis in Breast Cancer Cell Lines Through Mammalian Target of Rapamycin (mTOR) Pathway.

Authors:  Weipeng Zhao; Xichuan Li; Jun Wang; Chen Wang; Yongsheng Jia; Shunzong Yuan; Yong Huang; Yehui Shi; Zhongsheng Tong
Journal:  Med Sci Monit       Date:  2017-08-30

Review 8.  Relevance of Translation Initiation in Diffuse Glioma Biology and its Therapeutic Potential.

Authors:  Marina Digregorio; Arnaud Lombard; Paul Noel Lumapat; Félix Scholtes; Bernard Rogister; Natacha Coppieters
Journal:  Cells       Date:  2019-11-29       Impact factor: 6.600

Review 9.  Role of RONS and eIFs in Cancer Progression.

Authors:  Yasmeen Ahmed Salaheldin; Salma Sayed Mohamed Mahmoud; Ebenezeri Erasto Ngowi; Vivian Aku Gbordzor; Tao Li; Dong-Dong Wu; Xin-Ying Ji
Journal:  Oxid Med Cell Longev       Date:  2021-07-05       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.